304 related articles for article (PubMed ID: 27909743)
21. Inhibitory effects of aclarubicin on nitric oxide production in aortic smooth muscle cells and macrophages.
Wakabayashi I; Mayer B; Groschner K
Biochem Pharmacol; 2000 Mar; 59(6):719-26. PubMed ID: 10677589
[TBL] [Abstract][Full Text] [Related]
22. Bacterial toxins activation of abbreviated urea cycle in porcine cerebral vascular smooth muscle cells.
Mishra RG; Tseng TL; Chen MF; Chen PY; Lee TJ
Vascul Pharmacol; 2016 Dec; 87():110-120. PubMed ID: 27614253
[TBL] [Abstract][Full Text] [Related]
23. Arginase inhibition reduces interleukin-1β-stimulated vascular smooth muscle cell proliferation by increasing nitric oxide synthase-dependent nitric oxide production.
Yoon J; Ryoo S
Biochem Biophys Res Commun; 2013 Jun; 435(3):428-33. PubMed ID: 23665321
[TBL] [Abstract][Full Text] [Related]
24. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta.
Hecker M; Preiss C; Schini-Kerth VB
Br J Pharmacol; 1997 Mar; 120(6):1067-74. PubMed ID: 9134219
[TBL] [Abstract][Full Text] [Related]
25. Nitric oxide synthase inhibitors inhibit interleukin-1 beta-induced depression of vascular smooth muscle.
French JF; Lambert LE; Dage RC
J Pharmacol Exp Ther; 1991 Oct; 259(1):260-4. PubMed ID: 1717680
[TBL] [Abstract][Full Text] [Related]
26. Induction of nitric oxide synthase by protein synthesis inhibition in aortic smooth muscle cells.
Marczin N; Go CY; Papapetropoulos A; Catravas JD
Br J Pharmacol; 1998 Mar; 123(5):1000-8. PubMed ID: 9535031
[TBL] [Abstract][Full Text] [Related]
27. Halothane but not isoflurane attenuates interleukin 1beta-induced nitric oxide synthase in vascular smooth muscle.
Maeda H; Iranami H; Yamamoto M; Ogawa K; Morikawa Y; Senba E; Hatano Y
Anesthesiology; 2001 Aug; 95(2):492-9. PubMed ID: 11506125
[TBL] [Abstract][Full Text] [Related]
28. Localization of diacylglycerol kinase epsilon on stress fibers in vascular smooth muscle cells.
Nakano T; Hozumi Y; Goto K; Wakabayashi I
Cell Tissue Res; 2009 Jul; 337(1):167-75. PubMed ID: 19421779
[TBL] [Abstract][Full Text] [Related]
29. The anti-platelet agent, ticlopidine, upregulates interleukin-1-Beta-stimulated nitric oxide production in cultured rat vascular smooth muscle cells.
Inoue M; Kusano E; Ito C; Akimoto T; Iimura O; Nemoto J; Amemiya M; Muto S; Asano Y
Exp Nephrol; 2002; 10(4):267-74. PubMed ID: 12097830
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of inducible type nitric oxide synthase against intracellular oxidative stress caused by advanced glycation end-products in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats.
Mizutani K; Ikeda K; Ito T; Tamaki K; Nara Y; Yamori Y
J Hypertens; 2000 Aug; 18(8):1071-9. PubMed ID: 10953999
[TBL] [Abstract][Full Text] [Related]
31. Pressure stress reduces inducible NO synthase expression by interleukin-1β stimulation in cultured rat vascular smooth muscle cells.
Machida T; Iizuka K; Shinohara K; Hatakeyama N; Nakano K; Kubo Y; Hirafuji M
Eur J Pharmacol; 2014 May; 731():44-9. PubMed ID: 24632084
[TBL] [Abstract][Full Text] [Related]
32. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
Ueda S; Kato S; Matsuoka H; Kimoto M; Okuda S; Morimatsu M; Imaizumi T
Circ Res; 2003 Feb; 92(2):226-33. PubMed ID: 12574151
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of inducible NO synthase by exogenous adenosine in vascular smooth muscle cells activated by inflammatory stimuli in experimental diabetes.
Nassi A; Malorgio F; Tedesco S; Cignarella A; Gaion RM
Cardiovasc Diabetol; 2016 Feb; 15():32. PubMed ID: 26879172
[TBL] [Abstract][Full Text] [Related]
34. Adrenomedullin increases inducible nitric oxide synthase in rat vascular smooth muscle cells stimulated with interleukin-1.
Ikeda U; Kanbe T; Shimada K
Hypertension; 1996 Jun; 27(6):1240-4. PubMed ID: 8641730
[TBL] [Abstract][Full Text] [Related]
35. The effect of erythropoietin on interleukin-1beta mediated increase in nitric oxide synthesis in vascular smooth muscle cells.
Akimoto T; Kusano E; Muto S; Fujita N; Okada K; Saito T; Komatsu N; Ono S; Ebata S; Ando Y; Homma S; Asano Y
J Hypertens; 1999 Sep; 17(9):1249-56. PubMed ID: 10489101
[TBL] [Abstract][Full Text] [Related]
36. HMG-CoA reductase inhibitor enhances inducible nitric oxide synthase expression in rat vascular smooth muscle cells; involvement of the Rho/Rho kinase pathway.
Yamamoto T; Takeda K; Harada S; Nakata T; Azuma A; Sasaki S; Nakagawa M
Atherosclerosis; 2003 Feb; 166(2):213-22. PubMed ID: 12535733
[TBL] [Abstract][Full Text] [Related]
37. Post-transcriptional divergence in the regulation of CAT-2A, CAT-2B and iNOS expression by dexamethasone in vascular smooth muscle cells.
Thakur S; Baydoun AR
Amino Acids; 2012 Aug; 43(2):667-76. PubMed ID: 21997536
[TBL] [Abstract][Full Text] [Related]
38. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells.
Katsuyama K; Shichiri M; Kato H; Imai T; Marumo F; Hirata Y
Endocrinology; 1999 May; 140(5):2183-90. PubMed ID: 10218970
[TBL] [Abstract][Full Text] [Related]
39. Docetaxel inhibits cyclooxygenase-2 induction in vascular smooth muscle cells.
Nakano T; Goto K; Wakabayashi I
Eur J Pharmacol; 2011 Mar; 654(2):150-4. PubMed ID: 21185827
[TBL] [Abstract][Full Text] [Related]
40. Levosimendan inhibits interleukin-1β-induced apoptosis through activation of Akt and inhibition of inducible nitric oxide synthase in rat cardiac fibroblasts.
Okada M; Yamawaki H
Eur J Pharmacol; 2015 Dec; 769():86-92. PubMed ID: 26528797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
